EdgeCap-backed Comac Medical completed the acquisition of ILIFE.

EdgeCap-backed Comac Medical, a provider innovative and non-conventional solutions of high quality for unmet pharmaceutical industry needs, completed the acquisition of ILIFE, a Paris-based contract research organization specialized in early-phase oncology and biotech development. Financial terms were not disclosed. "Partnering with EdgeCap and Comac Medical Group marks an exciting new chapter for ILIFE. We share a deep commitment to quality, innovation, client-centric and agile service delivery," Marina Iché, ILIFE Founder and CEO.